Danielle Brander, MD, is a physician and assistant professor at the Duke Cancer Center, Duke University Medical Center, Durham, NC.
Dr Brander received her medical degree in 2007 from Duke University Medical Center. She then stayed at Duke and completed an internal medicine residency by 2010 and a fellowship in hematology oncology by 2013.
Speaking on chronic lymphocytic leukemia and novel therapies
Dr Brander focuses on treating patients with chronic lymphocytic leukemia (CLL) and developing novel therapies. She also leads a project investigating the combination of ibrutinib with novel PI3K inhibitors to treat patients with CLL, small lymphocytic leukemia and mantle cell lymphoma who have been previously treated.